36 participants
Autologous CD19 CAR-T Cell Therapy (SYNCAR-001) + Orthogonal IL-2 (STK-009) in Subjects With CD19+ Hematologic Malignancies
- Study Type:
- INTERVENTIONAL
- Last Updated:
- 2026-07-10
- Start Date:
- 2023-04-23
- Completion:
- 2028-06-24
Conditions
- CLL/SLL
- NHL
- Mantle Cell Lymphoma
- Follicular Lymphoma
- Large B-cell Lymphoma
- Indolent B-Cell Non-Hodgkin Lymphoma
- Diffuse Large B Cell Lymphoma
Interventions
- DRUG
No Results Yet